Organization
Jiaxing AnDiCon Biotech
4 clinical trials
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Study of the Safety and Efficacy of ADC189 Tablets in the Treatment of Influenza A Virus Infection/Influenza B Virus Infection in Adolescents and AdultsStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Phase I Study to Investigate the Absorption, Metabolism, Excretion, and Safety of [(14)C]ADC189 in Healthy Chinese Male VolunteersStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Comparison Study of ADC189 Bioavailability Between Tablet and Granule in Healthy Chinese Adult Male Subjects, and the Safety and Pharmacokinetics of Ultra-high Dose ADC189Status: Recruiting, Estimated PCD: 2024-07-03
Clinical trial
An Phase I, Open-label, Multi-center, Parallel, Single Oral Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ADC189 in Subjects With Hepatic Impairment (Child-Pugh A and B) Compared With Subjects With Normal Hepatic FunctionStatus: Recruiting, Estimated PCD: 2024-09-30